John Groskoph is currently Director New Products CMC, Global Chemistry Manufacturing and Controls at Pfizer, Inc. and has more than 17 years of pharmaceutical industry experience with a particular focus on CMC regulatory compliance. During his career at Pfizer, he has worked in a variety of quality operations and production assignments and brings experience in quality and compliance systems, post-approval change management and regulatory strategy. He joined the manufacturing control department in1998 as manager, manufacturing control. He was appointed director, global manufacturing compliance in 2001. In 2002, he took a one-year assignment in the Arnprior, Canada plant where he held various responsibilities in both the quality and manufacturing teams. Prior to his current position, Groskoph held the position of team leader, quality compliance Programs at the Parsippany, New Jersey manufacturing site. Groskoph holds a BS in electrical engineering from Lafayette College, Pennsylvania and an MBA from Columbia University, New York.from Columbia University, New York.